Anisha Chandra Mohan

Anisha is a Molecular Biology Fellow at Open Avenues Foundation where she leads experiential learning projects with students in Worcester. Anisha is the Senior Research Associate on the Next Generation Sequencing Team (NGS) at LifeMine Therapeutics, a company seeking to deliver a pipeline of naturally inspired drugs from eukaryotic microbes to treat human diseases. She previously worked as a Research Associate on the Molecular Biology and Virology group at Oncorus Inc, a biotechnology company that aims to deliver a novel immunotherapy to treat cancer patients. Prior to this, she worked as a Technical Associate I at the Koch Institute, MIT, on the Alternative Host Strain Engineering group which focuses on developing an integrative platform to manufacture therapeutic recombinant proteins using Yeast. Prior to this, she worked as the Research Technician at Tufts University, on projects focused on the understanding how genome instability caused by the expansion of trinucleotide repeat sequences, such as CAG/CTG sequences, contributes to human genetic diseases. She received her Master’s degree in Molecular and Cell Biology from Brandeis University and her Bachelor’s degree in Biotechnology from SRM University, India.